Coronation Fund Managers 13F: New $2M Stake in GEHC

On October 27, 2026, Coronation Fund Managers acquired 30,403 shares of GE HealthCare Technologies Inc. (GEHC), valued at approximately $1,987,444. This information comes from the fund's latest Form 13F filing with the SEC.

GEHC GE HealthCare Technologies Inc.

$71.11 ▼ -13.96% year to date

1M 3M YTD

Daily close · Oct 27, 2026

What Changed in Coronation Fund Managers' GE HealthCare Position

Coronation Fund Managers opened a new position in GE HealthCare, acquiring 30,403 shares. This new stake represents 0.11% of the fund's total reported value of about $1.75 billion, ranking it 33rd among its holdings.

Where GE HealthCare Fits in Coronation Fund Managers' Portfolio

This new position is relatively small, making up 0.11% of Coronation's portfolio.

Other Institutional Activity in GE HealthCare

Dodge & Cox Inc. holds 37,864,164 shares, worth about $2.69 billion after adding 6,553,353 shares. Barrow, Hanley Mewhinney & Strauss, LLC increased its stake by 1,571,152 shares, resulting in 13,455,814 shares valued at approximately $956.8 million. Hotchkis & Wiley Capital Management, LLC grew its holdings by 2,282,640 shares, bringing its total to 12,250,502 shares worth around $871.1 million.

GE HealthCare Technologies Inc. Stock Down 1.2%

As of October 28, 2026, GE HealthCare shares were trading at $71.11, equal to the closing price on the filing date. The stock is currently above its 50-day moving average by about 4.1% but below its 52-week high by about 20.8%.

Recent Earnings

For the trailing twelve months, GE HealthCare reported revenue of about $21.27 billion and earnings per share of $4.35. The next earnings report is set for October 28, 2026.

Dividend

GE HealthCare pays an annual dividend of $0.16 per share, which gives it a yield of 0.22%.

Analysts Set New Price Targets

On October 5, 2026, Citigroup maintained a Neutral rating on GE HealthCare with a price target of $71. On October 12, 2026, BTIG also maintained a Buy rating with a target of $75. The consensus among analysts is a Buy rating with a mean price target of $82.70 based on 20 opinions.

About GE HealthCare

GE HealthCare Technologies Inc. develops and markets medical devices and digital solutions for patient care. The company operates in multiple segments, including Imaging and Patient Care Solutions, focusing on improving diagnosis and treatment.

Bottom Line

Watch for GE HealthCare's upcoming earnings report on October 28, 2026, to see how it performs. This new position by Coronation Fund Managers highlights their interest in the healthcare sector, especially as the stock trades below its mean price target.